Surgical management of atherosclerotic renovascular disease
- PMID: 11854720
- DOI: 10.1067/mva.2002.120376
Surgical management of atherosclerotic renovascular disease
Abstract
Objective: This review describes the clinical outcome of surgical intervention for atherosclerotic renovascular disease in 500 consecutive patients with hypertension.
Methods: From January 1987 to December 1999, 626 patients underwent operative renal artery (RA) repair at our center. A subgroup of 500 patients (254 women and 246 men; mean age, 65 plus minus 9 years) with hypertension (mean blood pressure, 200 plus minus 35/104 plus minus 21 mm Hg) and atherosclerotic RA disease forms the basis of this report. Hypertension response was determined from preoperative and postoperative blood pressure measurements and medication requirements. Change in renal function was determined with estimated glomerular filtration rates (EGFRs) calculated from serum creatinine levels. Proportional hazards regression models were used for the examination of associations between selected preoperative parameters, blood pressure and renal function response, and eventual dialysis-dependence or death.
Results: Two hundred three patients underwent unilateral RA procedures, 297 underwent bilateral RA procedures, and 205 patients underwent combined renal and aortic reconstruction. After surgery, there were 23 deaths (4.6%) in the hospital or within 30 days of surgery. Significant and independent predictors of perioperative death included advanced age (P <.0001; hazard ratio [HR], 3.23; 95% confidence interval [CI], 1.85 to 5.70) and clinical congestive heart failure (P =.013; HR, 3.05; 95% CI, 1.26 to 7.34). Among the patients who survived surgery, hypertension was considered cured in 12%, improved in 73%, and unchanged in 15%. For the entire group, renal function increased significantly after operation (preoperative versus postoperative mean EGFR, 41.1 plus minus 23.9 versus 48.2 plus minus 25.5 mL/min/m(2); P <.0001). For individual patients, with a 20% or more change in EGFR considered significant, 43% had improved renal function (including 28 patients who were removed from dialysis-dependence), 47% had unchanged function, and 10% had worsened function. Preoperative renal insufficiency (P <.001; HR, 2.35; 95% CI, 1.86 to 2.98), diabetes mellitus (P =.007; HR, 2.14; 95% CI, 1.15 to 3.97), prior stroke (P =.042; HR, 1.50; 95% CI, 1.02 to 2.22), and severe aortic occlusive disease (P =.003; HR, 1.69; 95% CI, 1.19 to 2.31) showed significant and independent associations with death or dialysis during the follow-up examination period. After operation, blood pressure cured (P =.014; HR, 0.52; 95% CI, 0.30 to 0.88) and improved renal function (P =.011; HR, 0.40; 95% CI, 0.19 to 0.81) showed significant and independent associations with improved dialysis-free survival rate. All categories of function response and time to death or dialysis showed significant interactions with preoperative EGFR.
Conclusion: The surgical correction of atherosclerotic renovascular disease resulted in blood pressure benefit and retrieval of renal function in selected patients with hypertension. The patients with cured hypertension or improved EGFR after operation showed increased dialysis-free survival as compared with other patients who underwent surgery.
Similar articles
-
Management of ischemic nephropathy: dialysis-free survival after surgical repair.J Vasc Surg. 2000 Sep;32(3):472-81; discussion 481-2. doi: 10.1067/mva.2000.108637. J Vasc Surg. 2000. PMID: 10957653
-
Is renal revascularization in diabetic patients worthwhile?J Vasc Surg. 1996 Sep;24(3):383-92; discussion 392-3. doi: 10.1016/s0741-5214(96)70194-5. J Vasc Surg. 1996. PMID: 8808960
-
Surgery after failed percutaneous renal artery angioplasty.J Vasc Surg. 1999 Sep;30(3):468-82. doi: 10.1016/s0741-5214(99)70074-1. J Vasc Surg. 1999. PMID: 10477640
-
[Atherosclerotic renovascular hypertension: clinical findings and results of treatment over 15 years].Nefrologia. 2003;23(2):150-9. Nefrologia. 2003. PMID: 12778880 Review. Spanish.
-
The case for renal revascularization.Cardiovasc Surg. 1995 Apr;3(2):141-54. doi: 10.1016/0967-2109(95)90886-a. Cardiovasc Surg. 1995. PMID: 7606398 Review.
Cited by
-
Combined open and endovascular treatment of thoracoabdominal aortic pathologies: a systematic review and meta-analysis.Ann Cardiothorac Surg. 2012 Sep;1(3):267-76. doi: 10.3978/j.issn.2225-319X.2012.08.02. Ann Cardiothorac Surg. 2012. PMID: 23977508 Free PMC article.
-
Total Renal Artery Occlusion: Recovery of Function After Revascularization.Am J Kidney Dis. 2018 May;71(5):748-753. doi: 10.1053/j.ajkd.2017.11.014. Epub 2018 Feb 9. Am J Kidney Dis. 2018. PMID: 29429749 Free PMC article. Review.
-
Atherosclerotic Renal Artery Stenosis: A Review.Aorta (Stamford). 2021 Jun;9(3):95-99. doi: 10.1055/s-0041-1730004. Epub 2021 Oct 12. Aorta (Stamford). 2021. PMID: 34638148 Free PMC article.
-
Renal artery stenosis: medical versus interventional therapy.Curr Cardiol Rep. 2013 Oct;15(10):409. doi: 10.1007/s11886-013-0409-8. Curr Cardiol Rep. 2013. PMID: 23990274 Review.
-
Renal artery stenosis: optimizing diagnosis and treatment.Prog Cardiovasc Dis. 2011 Jul-Aug;54(1):29-35. doi: 10.1016/j.pcad.2011.02.007. Prog Cardiovasc Dis. 2011. PMID: 21722784 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous